Literature DB >> 19478427

Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix.

Yoshihiro Yamaguchi1, Genta Sato, Yuriko Yamagata, Yohei Doi, Jun-ichi Wachino, Yoshichika Arakawa, Koki Matsuda, Hiromasa Kurosaki.   

Abstract

The X-ray crystal structure of AmpC beta-lactamase (AmpC(D)) with a tripeptide deletion (Gly286-Ser287-Asp288) produced by Escherichia coli HKY28, a ceftazidime-resistant strain, was determined at a resolution of 1.7 A. The structure of AmpC(D) suggests that the tripeptide deletion at positions 286-288 located in the H10 helix causes a structural change of the Asn289-Asn294 region from the alpha-helix present in the native AmpC beta-lactamase of E. coli to a loop structure, which results in a widening of the substrate-binding site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478427      PMCID: PMC2688406          DOI: 10.1107/S1744309109014249

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  30 in total

1.  Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.

Authors:  G V Crichlow; A P Kuzin; M Nukaga; K Mayama; T Sawai; J R Knox
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

2.  Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.

Authors:  A Raimondi; F Sisto; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  beta -Lactamases: which ones are clinically important?

Authors:  Louis B. Rice; Robert A. Bonomo
Journal:  Drug Resist Updat       Date:  2000-06       Impact factor: 18.500

4.  Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime.

Authors:  Sergei B Vakulenko; Dasantila Golemi; Bruce Geryk; Maxim Suvorov; James R Knox; Shahriar Mobashery; Stephen A Lerner
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.

Authors:  S Trépanier; J R Knox; N Clairoux; F Sanschagrin; R C Levesque; A Huletsky
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

6.  Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.

Authors:  G Barnaud; R Labia; L Raskine; M J Sanson-Le Pors; A Philippon; G Arlet
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

7.  Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.

Authors:  Michiyoshi Nukaga; Sanjai Kumar; Kayoko Nukaga; R F Pratt; James R Knox
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

8.  Structure-based approach for binding site identification on AmpC beta-lactamase.

Authors:  Rachel A Powers; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

9.  Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.

Authors:  Yohei Doi; Jun-ichi Wachino; Masaji Ishiguro; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Keigo Shibayama; Keiko Yokoyama; Haru Kato; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.

Authors:  Hedi Mammeri; Laurent Poirel; Pascal Bemer; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  3 in total

Review 1.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

2.  Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion.

Authors:  Akito Kawai; Christi L McElheny; Alina Iovleva; Ellen G Kline; Nicolas Sluis-Cremer; Ryan K Shields; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

3.  Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog.

Authors:  Brandy N Curtis; Kali A Smolen; Sara J Barlow; Emilia Caselli; Fabio Prati; Magdalena A Taracila; Robert A Bonomo; Bradley J Wallar; Rachel A Powers
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.